RxDoctor Payments Data

Becky Calhoun-Harman

Family · Petersburg, WVNPI 1134298995

Payments from drug & device makers

$4,656in general payments, 2019–2025

Across 273 payments — averaging $17.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$788
  • Amgen$636
  • Novo Nordisk$531
  • AbbVie$427
  • Boehringer Ingelheim$424
  • Exact Sciences$287
  • plus $2K from 22 others

What the payments were for

  • Food & beverage$4,656100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,656 in reported general payments places this provider in the 90th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban45$42,631
MounjaroTirzepatide26$39,249
Trelegy ElliptaFluticasone/Umeclidin/Vilanter56$35,065
OzempicSemaglutide25$25,672
JardianceEmpagliflozin20$19,086
JanuviaSitagliptin Phosphate13$13,301
Breo ElliptaFluticasone/Vilanterol16$11,732
FarxigaDapagliflozin Propanediol11$10,694
Fluticasone-SalmeterolFluticasone Propion/Salmeterol19$2,818
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$2,530
ShingrixVaricella-Zoster Ge/As01b/Pf12$2,501
Potassium Chloride77$2,402
Advair DiskusFluticasone Propion/Salmeterol14$2,264
Memantine Hcl ErMemantine Hcl32$2,007
Boostrix TdapDiphth,pertuss(Acell),tet Vac29$1,849

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Shingrix$15$49,29884 claims
PfizerEliquis$64$42,63145 claims
Lilly USA, LLCMounjaro$143$39,24926 claims
Novo NordiskOzempic$531$25,67225 claims
Boehringer IngelheimJardiance$424$19,08620 claims
AstraZenecaFarxiga$788$10,69411 claims
AbbVieSynthroid$427$88214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,507 family providers in West Virginia.

Other family in Petersburg

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →